## **Core Concept**
Diabetic retinopathy is a complication of diabetes mellitus that affects the blood vessels in the retina, leading to potential vision loss. The management of diabetic retinopathy involves various treatment modalities aimed at preserving vision and preventing progression of the disease. Understanding the treatment options is crucial for effective patient care.

## **Why the Correct Answer is Right**
The correct answer, **Panretinal photocoagulation (PRP)**, is a laser treatment that is used for the management of diabetic retinopathy, particularly in cases with proliferative diabetic retinopathy (PDR) and severe non-proliferative diabetic retinopathy (NPDR). PRP works by ablating ischemic areas of the retina, which reduces the production of vascular endothelial growth factor (VEGF) and other factors that promote neovascularization. This treatment has been shown to reduce the risk of vision loss in patients with PDR.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Intravitreal bevacizumab (a VEGF inhibitor) is sometimes used off-label for diabetic macular edema and certain cases of proliferative diabetic retinopathy, but it is not the standard treatment for diabetic retinopathy as a whole.
- **Option B:** Systemic corticosteroids are not a primary treatment for diabetic retinopathy; they might be used in certain cases for associated conditions but are not standard therapy.
- **Option D:** Observation is not a treatment but rather a management approach for mild cases of diabetic retinopathy; it does not actively treat the condition.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **early detection and treatment of diabetic retinopathy are critical** to preventing vision loss. Regular eye examinations are recommended for all patients with diabetes. Panretinal photocoagulation (PRP) laser treatment is a cornerstone in the management of proliferative diabetic retinopathy.

## **Correct Answer:** C. Panretinal photocoagulation.